|
Title
|
|
|
|
Phase
|
|
|
|
Protocol IDs
|
|
|
|
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
|
|
|
|
Phase III
|
|
|
|
20040212
NCT00109031
|
|
|
Phase III of Unilateral Neck Irradiation With Amifostine in Patients With SCC of the Head and Neck
|
|
|
|
Phase III
|
|
|
|
186-03
ETH136-03D, NCT00206752
|
|
|
Light-Emitting Diode Therapy in Preventing Mucositis in Children
Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow
Transplantation
|
|
|
|
Phase II
|
|
|
|
MCW-HRRC-28600
MCW-CHW-0070, NCI-V02-1699, NCT00036712
|
|
|
Etanercept Mouthwash to Treat Stomatitis and Oral Pain in Patients Receiving Chemotherapy
|
|
|
|
Phase II
|
|
|
|
020133
02-NR-0133, NCT00031551
|
|
|
Cox-2 Inhibition in Radiation-Induced Oral Mucositis
|
|
|
|
Phase II
|
|
|
|
IRB 03 -157- 2
GCRC 487, Pfizer, Inc.: COXAON-0509-150, NCT00698204
|
|
|
Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer
|
|
|
|
Phase I
|
|
|
|
060206
06-D-0206, NCT00372320
|
|
|
Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma
|
|
|
|
Phase I
|
|
|
|
WSU-2006-119
WSU 2006-119, NCT00482846
|
|
|
A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis
|
|
|
|
Phase I
|
|
|
|
TRAUMEEL_S_Krempl
NCT00584597
|
|
|
Comparing Over-the-Counter Dry Mouth Remedies After Radiation
|
|
|
|
Phase I
|
|
|
|
Dry Mouth_Krempl
IRB # 12518, NCT00595933
|
|
|
Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
|
|
|
|
Phase I
|
|
|
|
PALSCT
NCT00701688
|
|